Demodex Blepharitis: The Lash Mites Behind Itchy Lids — and Where BlephEx Fits In

Few diagnoses make patients sit up like this one: the itching, crusting and stubbornly irritated lids you have been battling may be caused by mites living at the roots of your eyelashes. It sounds alarming. It is also common, treatable, and — once you understand the biology — entirely logical to manage. This article explains Demodex blepharitis and where in-office BlephEx debridement genuinely fits in its treatment.

What Demodex mites are

Two species of Demodex live on human skin: Demodex folliculorum, which colonises the lash follicle itself, and Demodex brevis, which burrows into the sebaceous and meibomian glands. Some level of colonisation is normal — these mites are part of the skin's ecosystem, and their numbers rise with age. Disease begins when the population overgrows: mites consume follicle cells, their waste and their own decomposing bodies trigger inflammation, and the follicle responds with the cylindrical, waxy debris that clinicians call collarettes — sleeves of dandruff-like material wrapped around the base of the lashes.

Collarettes matter because they are pathognomonic: a large prevalence study of US eye-care clinic patients (Trattler et al., 2022) treated collarettes as the defining sign and found them in roughly 58% of patients attending routine eye care — far more common than most patients, and many clinicians, assume. Demodex blepharitis is not rare; it is under-looked-for.

How we diagnose it

Diagnosis takes a slit lamp and a deliberate habit: asking the patient to look down, which rotates the lash roots into view. Collarettes at the lash base are the tell. Classic symptoms include itching that centres on the lash line (often worst in the morning), crusting, lid-margin redness, recurrent styes or chalazia, lash loss or misdirection, and dry-eye symptoms that never quite respond to drops. Because D. brevis occupies the meibomian glands, heavy infestation also feeds meibomian gland dysfunction — one reason Demodex and evaporative dry eye so often travel together.

The one rule every treatment must respect: the life cycle

A Demodex mite's life cycle — egg to adult — runs roughly two to three weeks. Any treatment that kills adult mites but not eggs will look like it worked, then fail as the next generation hatches. This is the single most common reason Demodex treatment “doesn't work”: it was stopped too early. Whatever the regime, plan for at least six weeks — two full life cycles — before judging it, and expect your optometrist to re-examine the lash line rather than rely on symptoms alone.

The treatment toolkit, honestly ranked

Tea tree oil and terpinen-4-ol

The traditional mainstay. Terpinen-4-ol, the active component of tea tree oil, is acaricidal — it kills mites — and is delivered as lid wipes, foams or in-office deep cleans. It works, but with two caveats: neat tea tree oil is toxic to the ocular surface and must never be self-applied undiluted, and a Cochrane systematic review concluded the supporting trial evidence, while suggestive, remains of limited certainty. Commercial terpinen-4-ol lid products used consistently for six weeks remain a reasonable, accessible first line.

Lotilaner 0.25% eye drops

The first pharmaceutical designed specifically for Demodex blepharitis — an anti-parasitic eye drop used twice daily for six weeks, with randomized-trial evidence (the SATURN programme) showing collarette clearance and mite eradication significantly better than vehicle drops. It was approved in the United States in 2023; availability in New Zealand is still limited, so ask your optometrist what is currently accessible here.

BlephEx — the mechanical strike

BlephEx microblepharoexfoliation attacks the problem physically. A spinning medical micro-sponge debrides the lash base, removing collarettes, eggs, mite debris and the biofilm the colony lives in — in about ten minutes, more thoroughly than weeks of home scrubbing. In Demodex specifically, that matters for three reasons: collarettes are the mite's protective habitat; debriding them exposes the follicle so that terpinen-4-ol or other topical treatment can actually reach the mites; and clearing the lash line gives the clinician a clean baseline against which regrowth — or genuine clearance — can be judged at the six-week review.

The honest frame from our main BlephEx article still applies: the best randomized evidence does not support BlephEx as a standalone cure for blepharitis, and a single debridement does not kill the mite population. Its role in Demodex is as the opening move of a six-week protocol — mechanical clearance first, acaricidal home therapy sustained for two life cycles after, hygiene habits kept up beyond that. That combination logic, debridement plus sustained topical treatment, is how our clinicians actually use it.

A realistic six-week plan

• Week 0: slit-lamp confirmation of collarettes; in-office BlephEx debridement of all four lids; start terpinen-4-ol (or other prescribed) lid therapy the same week.
• Weeks 1–6: daily lid treatment without gaps — consistency beats intensity; treat pillowcases and face towels with hot washes; avoid sharing eye makeup, and replace mascara used during active infestation.
• Week 6: re-examination of the lash line. Persisting collarettes mean the regime changes — not that nothing works.
• Beyond: Demodex overgrowth recurs in susceptible lids; a maintenance hygiene routine, with periodic repeat debridement where needed, protects the result.

When to suspect it in yourself

Morning lash-line itch, crusty roots that return days after cleaning, styes that keep coming back, or blepharitis that has shrugged off standard lid hygiene — any of these earns a deliberate look for collarettes. It is a two-minute check during any appointment with a Dry Eye Specialist Group practice, and it changes the whole treatment plan when positive. See our in-clinic treatments or book an assessment with your nearest member practice.

References

• Trattler W, Karpecki P, Rapoport Y, et al. The Prevalence of Demodex Blepharitis in US Eye Care Clinic Patients as Determined by Collarettes: A Pathognomonic Sign. Clinical Ophthalmology. 2022;16:1153-1164. PMID 35449733.
• Savla K, Le JT, Pucker AD. Tea tree oil for Demodex blepharitis. Cochrane Database of Systematic Reviews. 2020.
• Efficacy and Safety of Lotilaner Ophthalmic Solution (0.25%) for the Treatment of Demodex Blepharitis: A GRADE Assessed Systematic Review and Meta-Analysis. American Journal of Ophthalmology. 2024.
• Siegel M, et al. BlephEx-treatment for blepharitis: a prospective randomized placebo-controlled trial. BMC Ophthalmology. 2024. PMID 39558272.
• Jones L, Craig JP, Markoulli M, et al. TFOS DEWS III: Management and Therapy. American Journal of Ophthalmology. 2025;279:289-386.